Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2024-06-06
2025-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of MRI-PDFF to TAEUS FLIP Device to Estimate Liver Fat Fraction in Adults
NCT06373536
A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06487325
Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
NCT07192159
Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study
NCT04657523
Assessment of Fatty Liver with Thermo-acoustic Device
NCT04302051
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FAT PLUS
Echographic scan
Liver ultrasound exam
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echographic scan
Liver ultrasound exam
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is able to understand and sign the Informed Consent Form.
* Subject is able to stand and walk independently.
* Subject must have at least one or more routine ultrasound imaging procedures of the abdomen, at one of the participating study sites.
* Subject must have at least one routine liver MRI with PDFF score performed within 30 days before or after the ultrasound examination
* Subject is affiliated to National Social Insurance or a Health Insurance Regimen
Exclusion Criteria
* Subject is unable to understand the Informed Consent
* Subject is unable to express its consent
* Subject is under legal protection
* Subject is deprived of liberty by judicial or administrative decision
* Subject undergoes psychiatric treatment under constraint
* Subject is pregnant or breastfeeding
* Subject has latex allergy
* Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SuperSonic Imagine
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe Aubé, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Angers
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A00523-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.